Maternal cigarette smoking during pregnancy increases the risk of having a child with a congenital digital anomaly

Li-Xing Man1, Benjamin Chang

  • 1Division of Plastic Surgery, Health System, School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Insights

Maternal smoking during pregnancy increases the risk of congenital digital anomalies in newborns. This study found a significant dose-response relationship, highlighting smoking as a preventable risk factor.

Area of Science:

  • Reproductive Health
  • Teratology
  • Epidemiology

Background:

  • Investigated the link between maternal smoking and congenital digital anomalies.
  • Utilized the U.S. Natality database (2001-2002).

Purpose of the Study:

  • To determine if maternal cigarette smoking during pregnancy is associated with an increased risk of polydactyly, syndactyly, or adactyly.
  • To assess the dose-response relationship between smoking intensity and risk.

Main Methods:

  • Examined 6,839,854 live births.
  • Identified 5,171 newborns with isolated digital anomalies and 10,342 controls.
  • Adjusted for confounding factors like maternal marital status and medical conditions.

Main Results:

  • Maternal smoking during pregnancy was significantly associated with a higher risk of congenital digital anomalies (adjusted OR, 1.31).
  • A dose-response relationship was observed, with higher cigarette consumption per day leading to increased risk.
  • The risk increased with smoking intensity: 1-10 cigarettes/day (OR, 1.29), 11-20 cigarettes/day (OR, 1.38), and 21+ cigarettes/day (OR, 1.78).

Conclusions:

  • Maternal cigarette smoking is a significant risk factor for congenital digital anomalies.
  • The findings suggest that smoking cessation during pregnancy could be a key preventive strategy.
  • This study provides the largest evidence base to date on this specific association.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Genomic Imprinting and Inheritance02:30

Genomic Imprinting and Inheritance

Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...